Cargando…

Deletion of Nardilysin Prevents the Development of Steatohepatitis and Liver Fibrotic Changes

Nonalcoholic steatohepatitis (NASH) is an inflammatory form of nonalcoholic fatty liver disease that progresses to liver cirrhosis. It is still unknown how only limited patients with fatty liver develop NASH. Tumor necrosis factor (TNF)-α is one of the key molecules in initiating the vicious circle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishizu-Higashi, Shoko, Seno, Hiroshi, Nishi, Eiichiro, Matsumoto, Yoshihide, Ikuta, Kozo, Tsuda, Motoyuki, Kimura, Yoshito, Takada, Yutaka, Kimura, Yuto, Nakanishi, Yuki, Kanda, Keitaro, Komekado, Hideyuki, Chiba, Tsutomu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029810/ https://www.ncbi.nlm.nih.gov/pubmed/24849253 http://dx.doi.org/10.1371/journal.pone.0098017

Ejemplares similares

Nardilysin regulates inflammation, metaplasia, and tumors in murine stomach
por: Kimura, Yuto, et al.
Publicado: (2017)

Nardilysin and ADAM proteases promote gastric cancer cell growth by activating intrinsic cytokine signalling via enhanced ectodomain shedding of TNF-α
por: Kanda, Keitaro, et al.
Publicado: (2012)

Nardilysin in adipocytes regulates UCP1 expression and body temperature homeostasis
por: Saijo, Sayaka, et al.
Publicado: (2022)

Critical roles of nardilysin in the maintenance of body temperature homoeostasis
por: Hiraoka, Yoshinori, et al.
Publicado: (2014)

Genome-wide profiling of nardilysin target genes reveals its role in epigenetic regulation and cell cycle progression
por: Morita, Yusuke, et al.
Publicado: (2017)

Nardilysin is involved in autoimmune arthritis via the regulation of tumour necrosis factor alpha secretion
por: Fujii, Takayuki, et al.
Publicado: (2017)

Nardilysin promotes hepatocellular carcinoma through activation of signal transducer and activator of transcription 3
por: Kasai, Yosuke, et al.
Publicado: (2017)

Ultrastructural localization and distribution of Nardilysin in mammalian male germ cells
por: Segretain, D., et al.
Publicado: (2016)

Serum Nardilysin as a Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma
por: Xu, Yongfeng, et al.
Publicado: (2022)

Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer
por: Kawada, Mayumi, et al.
Publicado: (2011)

Visualization of stem cell activity in pancreatic cancer expansion by direct lineage tracing with live imaging
por: Maruno, Takahisa, et al.
Publicado: (2021)

New discriminant score to predict the fibrotic stage of non-alcoholic steatohepatitis in Japan
por: Kawamura, Yusuke, et al.
Publicado: (2015)

Nardilysin-Dependent Proteolysis of Cell-Associated VTCN1 (B7-H4) Marks Type 1 Diabetes Development
por: Radichev, Ilian A., et al.
Publicado: (2014)

A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis
por: McPherson, Stuart, et al.
Publicado: (2017)

Anti‐fibrotic activity of Euglena gracilis and paramylon in a mouse model of non‐alcoholic steatohepatitis
por: Nakashima, Ayaka, et al.
Publicado: (2018)

NRD1, which encodes nardilysin protein, promotes esophageal cancer cell invasion through induction of MMP2 and MMP3 expression
por: Uraoka, Naohiro, et al.
Publicado: (2014)

Lactate transporter MCT1 in hepatic stellate cells promotes fibrotic collagen expression in nonalcoholic steatohepatitis
por: Min, Kyounghee, et al.
Publicado: (2023)

Fibroscan-AST (FAST) score and other non-invasive tests for the diagnosis of fibrotic non-alcoholic steatohepatitis
por: Chan, Wah Loong, et al.
Publicado: (2023)

The role of the SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma
por: Tsuda, Motoyuki, et al.
Publicado: (2020)

Development of Disseminated Tuberculosis with Intestinal Involvement due to Adalimumab Administration Despite Latent Tuberculosis Treatment
por: Ikuta, Kozo, et al.
Publicado: (2019)

Efficacy of Dietary Lipid Control in Healing High-Fat and High-Cholesterol Diet-Induced Fibrotic Steatohepatitis in Rats
por: Tamada, Hazuki, et al.
Publicado: (2016)

Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell Populations
por: Heinrichs, Daniel, et al.
Publicado: (2021)

Inhibition of microRNA-33b in humanized mice ameliorates nonalcoholic steatohepatitis
por: Miyagawa, Sawa, et al.
Publicado: (2023)

Metabolomic analysis of fibrotic mice combined with public RNA‐Seq human lung data reveal potential diagnostic biomarker candidates for lung fibrosis
por: Nojima, Yosui, et al.
Publicado: (2020)

Hepatokine α1-Microglobulin Signaling Exacerbates Inflammation and Disturbs Fibrotic Repair in Mouse Myocardial Infarction
por: Hakuno, Daihiko, et al.
Publicado: (2018)

Dysregulated Bile Acid Synthesis, Metabolism and Excretion in a High Fat-Cholesterol Diet-Induced Fibrotic Steatohepatitis in Rats
por: Jia, Xiaofang, et al.
Publicado: (2013)

Secretome of senescent hepatic stellate cells favors malignant transformation from nonalcoholic steatohepatitis-fibrotic progression to hepatocellular carcinoma
por: Zhou, Yuan, et al.
Publicado: (2023)

Secretoglobin 3A2 Exhibits Anti-Fibrotic Activity in Bleomycin-Induced Pulmonary Fibrosis Model Mice
por: Cai, Yan, et al.
Publicado: (2015)

Lesser Omental Panniculitis
por: Nakamura, Masaharu, et al.
Publicado: (2020)

Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy
por: Nagaya, Tadanobu, et al.
Publicado: (2015)

Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1–3 fibrosis
por: Seko, Yuya, et al.
Publicado: (2018)

Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis
por: Alkhouri, Naim, et al.
Publicado: (2018)

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
por: Tokushige, Katsutoshi, et al.
Publicado: (2021)

Long‐term antitumor effect of lenvatinib on unresectable hepatocellular carcinoma with portal vein invasion
por: Takeda, Haruhiko, et al.
Publicado: (2019)

Utility of KRAS mutational analysis in the preoperative diagnosis of synchronous pancreatic cancer and intrahepatic cholangiocarcinoma: A case report
por: Eso, Yuji, et al.
Publicado: (2017)

Fibrotic Focus in Invasive Ductal Carcinoma: An Indicator of High Tumor Aggressiveness
por: Hasebe, Takahiro, et al.
Publicado: (1996)

Correction: Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis
por: Alkhouri, Naim, et al.
Publicado: (2018)

Hepatic gene expression and functional changes associated with nonalcoholic steatohepatitis
por: Matsumoto, Kana, et al.
Publicado: (2022)

Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target
por: Marangoni, Roberta G., et al.
Publicado: (2017)

Clinical characteristics of hypersensitivity pneumonitis: non-fibrotic and fibrotic subtypes
por: Chen, Xueying, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8nljoh61bloar2ovqfsed6pa18